Latest News

Late-Breaking Clinical Trial Presentations for Heart Failure Congress 2024 Revealed
Written by: Heart Failure 2024
Late-Breaking Clinical Trial Presentations for Heart Failure Congress 2024 Revealed
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at American College of Cardiology Congress
Written by: Radcliffe Cardiology
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented…
Findings from an Apolipoprotein B-Based Genetic Analysis
Written by: Radcliffe Cardiology
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
Written by: Heart Rhythm Society
WEARABLE CARDIOVERTER DEFIBRILLATORS PROVE TO BE SAFE FOR PEDIATRIC PATIENTS AT RISK FOR SUDDEN CARDIAC…
Written by: ESC Press Office
Serelaxin fails to meet primary endpoints in phase 3 RELAX-AHF-2 trial

External news

Written by: Academic - open access - HF
Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis
Written by: Academic - advance access - HF
Heart failure, infarction, and the seed of malignancy: stepping into the era of reverse cardio-oncology
Written by: Academic - advance access - HF
Safety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial
Written by: Academic - advance access - HF
Incident cancer in heart failure, myocardial infarction or both: a report from a global federated research network
Written by: Academic - advance access - HF
Prevalence and Predictors of High Inflammatory Risk in Heart Failure Subtypes: Findings From the Global POSEIDON Study
Written by: Academic - advance access - HF
Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study
Written by: Academic - advance access - HF
Short- and Long-Term Mortality in Patients Hospitalized for Dyspnoea with Acute Heart Failure, Respiratory Infection, or Both: Insights from the PARADISE Cohort
Written by: Academic - advance access - HF
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
Written by: Academic - advance access - HF
Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathy
Written by: Academic - open access - HF
Safety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial